Discover
RPTX
Repare Therapeutics Inc.
2.65
2 x 1.89
2 x 3.39
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
2.64 -0.01 (0.37%)
| Ytd | 1.92% | |
| 1y | 130.43% |
2.62
day range
2.65
52 week range
| Open | 2.64 | Prev Close | 2.65 | Low | 2.62 | High | 2.65 | Mkt Cap | N/A |
| Vol | 1.17M | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -0.45 |
| Beta | 0.71 | Short Ratio | 4.57 | Inst. Own | 83.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 8.50 |
| Income Statement | |||
| Total Revenue | 11.62M | ||
| Revenues (USD) | 11.62M | ||
| Gross Profit | 11.62M | ||
| Operating Expenses | 10.49M | ||
| Research and Development Expense | 7.50M | ||
| Selling, General and Administrative Expense | 4.55M | ||
| Operating Income | 1.13M | ||
| Income Tax Expense | 145.00K | ||
| Net Income | 3.26M | ||
| Net Income Common Stock | 3.26M | ||
| Net Income Common Stock (USD) | 3.26M | ||
| Consolidated Income | 3.26M | ||
| Earnings per Basic Share | 0.08 | ||
| Earnings per Basic Share (USD) | 0.08 | ||
| Earnings per Diluted Share | 0.08 | ||
| Earning Before Interest & Taxes (EBIT) | 3.40M | ||
| Earning Before Interest & Taxes (USD) | 3.40M | ||
| Weighted Average Shares | 42.97M | ||
| Weighted Average Shares Diluted | 43.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 72.83M | ||
| Cash and Equivalents (USD) | 72.83M | ||
| Investments | 41.50M | ||
| Investments Current | 39.78M | ||
| Investments Non-Current | 1.72M | ||
| Trade and Non-Trade Receivables | 6.49M | ||
| Current Assets | 124.43M | ||
| Total Assets | 126.75M | ||
| Debt Current | 342.00K | ||
| Total Debt | 342.00K | ||
| Current Liabilities | 11.62M | ||
| Total Liabilities | 11.62M | ||
| Accumulated Retained Earnings (Deficit) | -461.33M | ||
| Accumulated Other Comprehensive Income | 14.00K | ||
| Shareholders Equity | 115.13M | ||
| Shareholders Equity (USD) | 115.13M | ||
| Assets Non-Current | 2.32M | ||
| Total Debt (USD) | 342.00K | ||
| Trade and Non-Trade Payables | 1.33M | ||
| Tax Assets | 1.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 371.00K | ||
| Net Cash Flow from Financing | 30.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.17M | ||
| Issuance (Purchase) of Equity Shares | 30.00K | ||
| Net Cash Flow from Investing | 2.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.54M | ||
| Net Cash Flow from Operations | 2.65M | ||
| Effect of Exchange Rate Changes on Cash | -49.00K | ||
| Share Based Compensation | 1.41M | ||